google-site-verification: googlec7193c3de77668c9.html

FDA approves Exdensur for severe asthma

[
The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adult and pediatric patients aged 12 years and older.


Source link

Advertisements
Views: 0

See also  Business Daily - Fighting economic abuse

Check Also

Why every mother deserves the right to choose

[ Credit: Unsplash/CC0 Public Domain In many cultures, the placenta is more than tissue left …

WHO declares Hantavirus outbreak linked to cruise ship is over

On Thursday, the WHO said more than 650 contacts had been identified and followed up …

COVID’s lingering shadow faded after omicron—but not for everyone

[ For some, COVID-19 did not end when the infection cleared. A long-term study found …

Leave a Reply

Available for Amazon Prime